Safe Co-Administration of Anastrozole and Valacyclovir

Mechanism and Safety Assessment

• Anastrozole and valacyclovir have independent mechanisms with no overlapping metabolic pathways, as anastrozole inhibits the aromatase enzyme and valacyclovir works through viral DNA polymerase inhibition, according to the Centers for Disease Control and Prevention (CDC) guidelines 1

Clinical Context and Dosage

• Patients with breast cancer on anastrozole may require valacyclovir for herpes simplex virus (HSV) or varicella-zoster virus (VZV) infections, and the standard valacyclovir dosing remains unchanged when co-administered with anastrozole, as recommended by the National Comprehensive Cancer Network (NCCN) 1, 2

Monitoring Considerations

• Patients on anastrozole require ongoing monitoring for bone health, musculoskeletal symptoms, and cardiovascular risk factors, which are unrelated to valacyclovir use, as suggested by medical insights 3